Biontech Se (BNTX): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Biontech Se (BNTX) following the 2026 Q1 hedge fund 13F filings?

As of today, BNTX has moved +1.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -4.9%. Since the quarter end (March 31, 2026), BNTX gained +1.9% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Biontech Se (BNTX)

267 + Investors. Track Smart Money conviction in BNTX. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — BNTX

Based on 270 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds reduced or closed their BNTX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

📊

High ownership — 89% of 3.0Y peak

89% of all-time peak

270 funds currently hold this stock — 89% of the 3.0-year high of 303 funds (reached 2024 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

📉

Outflows — 4% fewer funds vs a year ago

fund count last 6Q

10 fewer hedge funds hold BNTX compared to a year ago (-4% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.

🟡

Slight buying edge — 52% buying

141 buying132 selling

Last quarter: 141 funds bought or added vs 132 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

⚠️

Fewer new buyers each quarter (-23 vs last Q)

new funds entering per quarter

Funds opening this position for the first time: 35 → 32 → 65 → 42. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.

🔒

58% of holders stayed for 2+ years

■ 58% conviction (2yr+) ■ 24% medium ■ 18% new

157 out of 270 hedge funds have held BNTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💎

Buying through price weakness — shares +1%, value -17%

Value

-17%

+1%

Last quarter: funds added +1% more shares while total portfolio value only changed -17%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

🚀

Acceleration phase — new buyers rushing in

39 → 35 → 32 → 65 → 42 new funds/Q

New funds entering each quarter: 35 → 32 → 65 → 42. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🏛️

Deep conviction — 64% of holders stayed 2+ years

■ 64% veterans ■ 17% 1-2yr ■ 19% new

Of 300 current holders: 192 (64%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.

🏆

Elite ownership — 63% AUM from top-100 funds

63% from top-100 AUM funds

53 of 270 holders are among the 100 largest funds by AUM, controlling 63% of total institutional value in BNTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

3.0

out of 10

Low Exit Risk

Exit risk score 3.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	267	282	-5.32%
13F Shares	49M	49M	1.09%
Total Value	$3.79B	$4.61B	-17.79%
New Positions	42	65	-23
Increased Positions	92	84	+8
Closed Positions	57	40	+17
Reduced Positions	70	78	-8
Total Calls	13	18	-27.78%
Total Puts	17	18	-5.56%
PUT/CALL Ratio	1.31	1.0	Bearish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

267

282

-5.32%

13F Shares

49M

1.09%

Total Value

$3.79B

$4.61B

-17.79%

New Positions

-23

Increased Positions

Closed Positions

+17

Reduced Positions

-8

Total Calls

-27.78%

Total Puts

-5.56%

PUT/CALL Ratio

1.31

1.0

Bearish

Institutional Holders (2026 Q1)

267 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BNTX. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 BNTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	GSK plc	13.20%	889,824	$79.1M
2	Davern Capital Partners, LP	7.44%	305,055	$27.1M
3	Tang Capital Management LLC	2.12%	470,000	$41.8M
4	Crocodile Capital Partners GmbH	2.02%	29,586	$2.8M
5	Sectoral Asset Management Inc	1.69%	22,164	$2.0M
6	Flossbach von Storch Se	1.53%	3,680,315	$327.1M
7	Long Focus Capital Management, LLC	1.46%	624,000	$55.5M
8	Quinn Opportunity Partners LLC	1.06%	228,832	$20.3M
9	Baader Bank Aktiengesellschaft	0.94%	136,425	$12.0M
10	CenterBook Partners LP	0.82%	171,166	$15.2M
11	Systrade AG	0.60%	10,000	$889K
12	Slow Capital, Inc.	0.55%	47,706	$4.2M
13	Arrowpoint Investment Partners (Singapore) Pte. Ltd.	0.54%	6,890	$612K
14	Ground Swell Capital, LLC	0.51%	2,904	$258K
15	Privium Fund Management B.V.	0.50%	27,000	$2.4M
16	AlphaCentric Advisors LLC	0.50%	5,616	$499K
17	Lbp AM SA	0.47%	385,109	$34.2M
18	Temasek Holdings (Private) Ltd	0.44%	1,506,027	$133.9M
19	Longaeva Partners L.P.	0.39%	119,204	$10.6M
20	Palo Alto Investors LP	0.27%	19,614	$1.7M
21	Primecap Management Co/Ca/	0.27%	3,793,711	$337.2M
22	Groupama Asset Managment	0.24%	185,036	$16.4M
23	Candriam S.C.A.	0.23%	488,367	$43.4M
24	Virtus Investment Advisers, LLC	0.22%	8,904	$791K
25	Mirabaud & Cie SA	0.22%	6,000	$533K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Biontech Se (BNTX)

What does the Smart Money Trend signal show for BNTX?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their BNTX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for BNTX?

Slight buying edge — 52% buying: Last quarter: 141 funds bought or added vs 132 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for BNTX holders?

Elite ownership — 63% AUM from top-100 funds: 53 of 270 holders are among the 100 largest funds by AUM, controlling 63% of total institutional value in BNTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held BNTX?

58% of holders stayed for 2+ years: 157 out of 270 hedge funds have held BNTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Biontech Se (BNTX) following the 2026 Q1 hedge fund 13F filings?

As of today, BNTX has moved +1.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -4.9%. Since the quarter end (March 31, 2026), BNTX has gained +1.9% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Biontech Se (BNTX)

Smart Money Signals — BNTX

Selling streak — 1 quarter in a row

High ownership — 89% of 3.0Y peak

Outflows — 4% fewer funds vs a year ago

Slight buying edge — 52% buying

Fewer new buyers each quarter (-23 vs last Q)

58% of holders stayed for 2+ years

Buying through price weakness — shares +1%, value -17%

Acceleration phase — new buyers rushing in

Deep conviction — 64% of holders stayed 2+ years

Elite ownership — 63% AUM from top-100 funds

Institutional Sentiment Summary — BNTX

Hedge Fund Ownership: BNTX

Market Analysis: BNTX

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: BNTX

Is It Too Late to Buy Biontech Se (BNTX) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: BNTX

Statistics: BNTX

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Biontech Se (BNTX)

Welcome to 13Foresight!